Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Apr;114(8):1625–1630. doi: 10.1111/j.1476-5381.1995.tb14949.x

The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity.

A J Cross 1, J A Jones 1, M Snares 1, K G Jostell 1, U Bredberg 1, A R Green 1
PMCID: PMC1510393  PMID: 7599932

Abstract

1. The effect of chlormethiazole administration on delayed neuronal death in gerbil hippocampus following transient global ischaemia has been examined. Chlormethiazole was administered either intraperitoneally or by intravenous infusion with either the dose or the time of infusion varied. 2. Chlormethiazole (600 mumol kg-1, i.p.) given 60 min after ischaemia produced substantial (> 60%) neuroprotection when damage was assessed 5, 14 or 21 days later, indicating the drug does not merely delay cell death. 3. Infusion protocols were developed which would result in sustained and defined plasma concentrations. Chlormethiazole (930 mumol kg-1) was then infused intravenously for 30 min, 76.5 min or 110 min in ways resulting in sustained plasma concentrations of 200, 100 and 50 nmol ml-1 respectively. When treatment was initiated 30 min after the ischaemic episode all protocols provided effective neuroprotection. There was a dose-dependent decline in protection when plasma chlormethiazole concentrations of 50, 30 and 10 nmol ml-1 were sustained for 110 min with no protection observed at 10 nmol ml-1. 4. In contrast, when a plasma concentration of 10 nmol ml-1 was sustained by infusion for 24 h, almost total neuroprotection against the ischaemic damage was achieved. This plasma concentration produced no sedative or anticonvulsant activity. 5. These data suggest that neuroprotection depends on both dose and duration of chlormethiazole administration and that excellent neuroprotection is possible in the absence of the sedative and anticonvulsant effects of the drug.

Full text

PDF
1625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin H. A., Williams J. L., Snares M., Ferreira T., Cross A. J., Green A. R. Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. Br J Pharmacol. 1994 May;112(1):188–194. doi: 10.1111/j.1476-5381.1994.tb13050.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Busto R., Dietrich W. D., Globus M. Y., Valdés I., Scheinberg P., Ginsberg M. D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab. 1987 Dec;7(6):729–738. doi: 10.1038/jcbfm.1987.127. [DOI] [PubMed] [Google Scholar]
  3. Cross A. J., Jones J. A., Baldwin H. A., Green A. R. Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil. Br J Pharmacol. 1991 Oct;104(2):406–411. doi: 10.1111/j.1476-5381.1991.tb12443.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gill R., Foster A. C., Woodruff G. N. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci. 1987 Oct;7(10):3343–3349. doi: 10.1523/JNEUROSCI.07-10-03343.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Green A. R., Cross A. J. The neuroprotective actions of chlormethiazole. Prog Neurobiol. 1994 Dec;44(5):463–484. doi: 10.1016/0301-0082(94)90007-8. [DOI] [PubMed] [Google Scholar]
  6. Green A. R., Murray T. K. A simple intravenous infusion method in rodents for determining the potency of anticonvulsants acting through GABAergic mechanisms. J Pharm Pharmacol. 1989 Dec;41(12):879–880. doi: 10.1111/j.2042-7158.1989.tb06395.x. [DOI] [PubMed] [Google Scholar]
  7. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982 May 6;239(1):57–69. doi: 10.1016/0006-8993(82)90833-2. [DOI] [PubMed] [Google Scholar]
  8. Pentikäinen P. J., Neuvonen P. J., Jostell K. G. Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liver. Eur J Clin Pharmacol. 1980 Apr;17(4):275–284. doi: 10.1007/BF00625801. [DOI] [PubMed] [Google Scholar]
  9. Scott D. B., Beamish D., Hudson I. N., Jostell K. G. Prolonged infusion of chlormethiazole in intensive care. Br J Anaesth. 1980 May;52(5):541–545. doi: 10.1093/bja/52.5.541. [DOI] [PubMed] [Google Scholar]
  10. Snape M. F., Baldwin H. A., Cross A. J., Green A. R. The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience. 1993 Apr;53(3):837–844. doi: 10.1016/0306-4522(93)90628-s. [DOI] [PubMed] [Google Scholar]
  11. Sydserff S. G., Cross A. J., West K. J., Green A. R. The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia. Br J Pharmacol. 1995 Apr;114(8):1631–1635. doi: 10.1111/j.1476-5381.1995.tb14950.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Valentino K., Newcomb R., Gadbois T., Singh T., Bowersox S., Bitner S., Justice A., Yamashiro D., Hoffman B. B., Ciaranello R. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7894–7897. doi: 10.1073/pnas.90.16.7894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wagner J. G. A safe method for rapidly achieving plasma concentration plateaus. Clin Pharmacol Ther. 1974 Oct;16(4):691–700. doi: 10.1002/cpt1974164691. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES